These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36358862)

  • 1. Classic and New Markers in Diagnostics and Classification of Breast Cancer.
    Beňačka R; Szabóová D; Guľašová Z; Hertelyová Z; Radoňák J
    Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA hsa_circ_0043278 inhibits breast cancer progression via the miR-455-3p/EI24 signalling pathway.
    Shi Y; Liu C
    BMC Cancer; 2021 Nov; 21(1):1249. PubMed ID: 34800978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
    Moi L; Braaten T; Al-Shibli K; Lund E; Busund LR
    J Transl Med; 2019 Oct; 17(1):334. PubMed ID: 31581940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-microRNA Biomarker Signatures to Classify Breast Cancer Subtypes.
    Oztemur Islakoglu Y; Noyan S; Aydos A; Gur Dedeoglu B
    OMICS; 2018 Nov; 22(11):709-716. PubMed ID: 30388053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.
    Lowery AJ; Miller N; Devaney A; McNeill RE; Davoren PA; Lemetre C; Benes V; Schmidt S; Blake J; Ball G; Kerin MJ
    Breast Cancer Res; 2009; 11(3):R27. PubMed ID: 19432961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative levels of let-7a, miR-17, miR-27b, miR-125a, miR-125b and miR-206 as potential molecular markers to evaluate grade, receptor status and molecular type in breast cancer.
    Lehmann TP; Korski K; Gryczka R; Ibbs M; Thieleman A; Grodecka-Gazdecka S; Jagodziński PP
    Mol Med Rep; 2015 Sep; 12(3):4692-4702. PubMed ID: 26130254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA hsa_circRNA_002178 silencing retards breast cancer progression via microRNA-328-3p-mediated inhibition of COL1A1.
    Liu T; Ye P; Ye Y; Lu S; Han B
    J Cell Mol Med; 2020 Feb; 24(3):2189-2201. PubMed ID: 31957232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
    Bastien RR; Rodríguez-Lescure Á; Ebbert MT; Prat A; Munárriz B; Rowe L; Miller P; Ruiz-Borrego M; Anderson D; Lyons B; Álvarez I; Dowell T; Wall D; Seguí MÁ; Barley L; Boucher KM; Alba E; Pappas L; Davis CA; Aranda I; Fauron C; Stijleman IJ; Palacios J; Antón A; Carrasco E; Caballero R; Ellis MJ; Nielsen TO; Perou CM; Astill M; Bernard PS; Martín M
    BMC Med Genomics; 2012 Oct; 5():44. PubMed ID: 23035882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA hsa_circ_0072995 promotes breast cancer cell migration and invasion through sponge for miR-30c-2-3p.
    Zhang HD; Jiang LH; Hou JC; Zhou SY; Zhong SL; Zhu LP; Wang DD; Yang SJ; He YJ; Mao CF; Yang Y; Wang JY; Zhang Q; Xu HZ; Yu DD; Zhao JH; Tang JH; Ji ZL
    Epigenomics; 2018 Sep; 10(9):1229-1242. PubMed ID: 30182731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Detection of HER2, Ki67, and GSTP1 Genes on the Diagnosis and Prognosis of Breast Cancer.
    Song B; Wang L; Zhang Y; Li N; Dai H; Xu H; Cai H; Yan J
    Cancer Biother Radiopharm; 2019 Mar; 34(2):85-90. PubMed ID: 30585764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsa_circ_0102485 inhibits the growth of cancer cells by regulating the miR-188-3p/ARID5B/AR axis in prostate carcinoma.
    Chen Z; Fu S; Shan Y; Li H; Wang H; Liu J; Wang W; Huang Y; Huang H; Wang J; Ding M
    Pathol Res Pract; 2022 Sep; 237():154052. PubMed ID: 35939970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation of p16, BRCA1 and RASSF1A genes in triple-negative breast cancer patients from Serbia.
    Kozomara Z; Supic G; Krivokuca A; Magic Z; Dzodic R; Milovanovic Z; Brankovic-Magic M
    J BUON; 2018; 23(3):684-691. PubMed ID: 30003738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of immunohistochemistry, copy number aberrations and epigenetic disorders with BRCAness pattern in hereditary and sporadic breast cancer.
    Murria Estal R; Palanca Suela S; de Juan Jiménez I; Alenda Gonzalez C; Egoavil Rojas C; García-Casado Z; López Guerrero JA; Juan Fita MJ; Sánchez Heras AB; Segura Huerta Á; Santaballa Bertrán A; Chirivella González I; Llop García M; Pérez Simó G; Barragán González E; Bolufer Gilabert P
    Fam Cancer; 2016 Apr; 15(2):193-200. PubMed ID: 26723934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer.
    Chen L; Chen Y; Xie Z; Luo J; Wang Y; Zhou J; Huang L; Li H; Wang L; Liu P; Shu M; Zhang W; Ke Z
    Breast Cancer Res Treat; 2022 Aug; 194(3):517-529. PubMed ID: 35789315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a circRNA-miRNA-mRNA Regulated Pathway Involved in EGFR-TKI Lung Adenocarcinoma Resistance.
    Dai C; Liu B; Li S; Hong Y; Si J; Xiong Y; Wu N; Ma Y
    Technol Cancer Res Treat; 2021; 20():15330338211056809. PubMed ID: 34825849
    [No Abstract]   [Full Text] [Related]  

  • 16. Circular RNA_0006014 promotes breast cancer progression through sponging miR-885-3p to regulate NTRK2 and PIK3/AKT pathway.
    Zhou X; Jian W; Luo Q; Zheng W; Deng X; Wang X; Borkhuu O; Ji C; Li D; Fang L
    Aging (Albany NY); 2022 Apr; 14(7):3105-3128. PubMed ID: 35383130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsa_circ_0053063 inhibits breast cancer cell proliferation via hsa_circ_0053063/hsa-miR-330-3p/PDCD4 axis.
    Ji C; Hu J; Wang X; Zheng W; Deng X; Song H; Yu Y; Luo Q; Hua K; Zhou X; Fang L
    Aging (Albany NY); 2021 Mar; 13(7):9627-9645. PubMed ID: 33744861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circlular RNA BARD1 (Hsa_circ_0001098) overexpression in breast cancer cells with TCDD treatment could promote cell apoptosis via miR-3942/BARD1 axis.
    Zhao J; Zou H; Han C; Ma J; Zhao J; Tang J
    Cell Cycle; 2018; 17(24):2731-2744. PubMed ID: 30521417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated microRNA-125b levels predict a worse prognosis in HER2-positive breast cancer patients.
    Luo Y; Wang X; Niu W; Wang H; Wen Q; Fan S; Zhao R; Li Z; Xiong W; Peng S; Zeng Z; Li X; Li G; Tan M; Zhou M
    Oncol Lett; 2017 Feb; 13(2):867-874. PubMed ID: 28356971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue.
    Quesne JL; Jones J; Warren J; Dawson SJ; Ali HR; Bardwell H; Blows F; Pharoah P; Caldas C
    J Pathol; 2012 Jul; 227(3):306-14. PubMed ID: 22294324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.